tradingkey.logo

Bioventus Inc

BVS
7.450USD
-0.030-0.40%
Fechamento 11/07, 16:00ETCotações atrasadas em 15 min
498.95MValor de mercado
63.80P/L TTM

Mais detalhes de Bioventus Inc Empresa

Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.

Informações de Bioventus Inc

Código da empresaBVS
Nome da EmpresaBioventus Inc
Data de listagemFeb 11, 2021
CEOMr. Robert E. Claypoole
Número de funcionários930
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 11
Endereço4721 Emperor Boulevard, Suite 100
CidadeDURHAM
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal27703
Telefone19194746700
Sitehttps://www.bioventus.com/
Código da empresaBVS
Data de listagemFeb 11, 2021
CEOMr. Robert E. Claypoole

Executivos da empresa Bioventus Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
134.37K
+7.98%
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+33.34%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
100.12K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+45.10%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+74.79%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+53.05%
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Independent Director
Independent Director
74.70K
+54.96%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
11.70K
--
Mr. Mark Singleton
Mr. Mark Singleton
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Ms. Katrina Church, J.D.
Ms. Katrina Church, J.D.
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
134.37K
+7.98%
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+33.34%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
100.12K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+45.10%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+74.79%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+53.05%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Pain Treatments and Joint Preservation
73.31M
49.65%
Surgical solutions
52.72M
35.70%
Restorative Therapies
21.64M
14.65%
Por RegiãoUSD
Nome
Receita
Proporção
United States
128.78M
87.21%
International
18.89M
12.79%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Pain Treatments and Joint Preservation
73.31M
49.65%
Surgical solutions
52.72M
35.70%
Restorative Therapies
21.64M
14.65%

Distribuição de ações

Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
EW Healthcare Partners
19.44%
Juniper Investment Company, LLC
10.36%
Smith & Nephew Group plc
9.30%
Nantahala Capital Management, LLC
7.88%
The Vanguard Group, Inc.
4.30%
Outro
48.72%
Investidores
Investidores
Proporção
EW Healthcare Partners
19.44%
Juniper Investment Company, LLC
10.36%
Smith & Nephew Group plc
9.30%
Nantahala Capital Management, LLC
7.88%
The Vanguard Group, Inc.
4.30%
Outro
48.72%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
24.06%
Venture Capital
19.47%
Investment Advisor
15.71%
Hedge Fund
12.08%
Corporation
9.31%
Individual Investor
2.54%
Research Firm
1.14%
Insurance Company
0.47%
Bank and Trust
0.35%
Outro
14.87%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
314
49.29M
73.59%
-10.48M
2025Q2
317
56.37M
84.27%
-8.06M
2025Q1
320
55.18M
83.57%
-8.66M
2024Q4
318
53.79M
82.30%
-10.70M
2024Q3
319
53.14M
81.61%
-8.49M
2024Q2
288
54.91M
84.63%
-3.42M
2024Q1
287
52.64M
83.27%
-7.74M
2023Q4
285
51.63M
82.02%
-9.27M
2023Q3
276
51.61M
82.33%
-9.01M
2023Q2
273
50.56M
81.06%
-10.51M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
EW Healthcare Partners
13.02M
19.47%
--
--
Jun 30, 2025
Juniper Investment Company, LLC
6.94M
10.37%
--
--
Jun 30, 2025
Smith & Nephew Group plc
6.23M
9.31%
--
--
Apr 07, 2025
Nantahala Capital Management, LLC
5.28M
7.89%
+1.16M
+28.00%
Jun 30, 2025
The Vanguard Group, Inc.
2.77M
4.14%
+223.28K
+8.77%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.82M
4.21%
+259.59K
+10.15%
Jun 30, 2025
American Century Investment Management, Inc.
1.12M
1.68%
+79.83K
+7.64%
Jun 30, 2025
Royce Investment Partners
1.09M
1.63%
+199.86K
+22.40%
Jun 30, 2025
Divisadero Street Capital Management, LP
1.08M
1.62%
-611.52K
-36.14%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.05M
1.58%
+122.14K
+13.09%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
Vanguard US Multifactor ETF
0.11%
VictoryShares Small Cap Free Cash Flow ETF
0.09%
Harbor Human Capital Factor US Small Cap ETF
0.09%
Fidelity Enhanced Small Cap ETF
0.07%
iShares Micro-Cap ETF
0.06%
Vanguard US Value Factor ETF
0.04%
Principal U.S. Small-Cap ETF
0.04%
Humankind US Stock ETF
0.03%
WisdomTree US SmallCap Fund
0.03%
Avantis US Small Cap Value ETF
0.03%
Ver Mais
Vanguard US Multifactor ETF
Proporção0.11%
VictoryShares Small Cap Free Cash Flow ETF
Proporção0.09%
Harbor Human Capital Factor US Small Cap ETF
Proporção0.09%
Fidelity Enhanced Small Cap ETF
Proporção0.07%
iShares Micro-Cap ETF
Proporção0.06%
Vanguard US Value Factor ETF
Proporção0.04%
Principal U.S. Small-Cap ETF
Proporção0.04%
Humankind US Stock ETF
Proporção0.03%
WisdomTree US SmallCap Fund
Proporção0.03%
Avantis US Small Cap Value ETF
Proporção0.03%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI